Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Critical Illness Insurance Market: By Product Type, By Application, and Region Forecast 2019-2030
Critical Illness Insurance Market size was valued at US$ 120.2 billion in 2023 and is poised to grow at a CAGR of 10.5% from 2024-2030. The growing elderly population and this group's high susceptibility to various chronic diseases are exp, expected to drive the market. Individuals aged 65 and up who are afflicted with a sickness usually require close monitoring and surgical operations. The elderly members of society cannot afford costly medical treatment and surgical procedures, and more extended hospital stays may act as a catalyst for market growth. The availability of numerous critical illness insurance coverages and the opportunity to select one promotes business growth. The vital illness insurance sector benefits from increased GDP and rising healthcare spending.
According to the WHO's Cancer Profile 2020 report, global cancer incidence was 18.06 million in 2018, with 9.57 million deaths. As a result, the worldwide market is likely to be driven by the rising prevalence of critical illness. A fundamental trend impacting the critical insurance market is a rise in critical conditions covered by critical illness insurance policies. Aside from cancer, stroke, coronary artery bypass, and heart attack, major insurance companies are working on expanding coverage for many new conditions such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, and motor neuron diseases. Critical illness insurance has been gaining traction over the past two decades. It's popular in Australia, the UK, and emerging countries. The rising number of baby boomers in the U.S. is the primary factor expected to impact the market positively. Insurance is very attractive to middle-aged and old-aged people. Critical illness insurance covers cancer, heart attack, kidney failure, and stroke, core diseases. The surge in the geriatric population in China, India, Japan, and other countries, increased awareness levels expected to fuel the market shortly.
Study Period
2024-2030Base Year
2023CAGR
10.5%Largest Market
Asia-PacificFastest Growing Market
Asia Pacific
The rising prevalence of acute diseases is driving the worldwide critical illness insurance industry. Treatment for a critical illness such as cancer can be pretty expensive. Therefore, having critical illness insurance can help mitigate some of the financial load. With the increased need for critical illness insurance in the worldwide market, there will be good growth potential in the future. However, the worldwide critical insurance business is being held back by a lack of awareness regarding critical illness insurance. The majority of critical illness insurance comes standard with term plans. The majority of people are aware of life insurance plans, but few are aware of term insurance plans.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 120.2 billion |
Market CAGR |
10.5% |
By Product Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The critical illness insurance market size was valued at US$ 120.2 billion in 2023 and is set to grow at a significant CAGR of 10.5% from 2024-2030.
Aegon N.V., Allianz SE, Aviva plc, Axa S.A., China Life Insurance
Asia Pacific is the fastest-growing region in the market
1.Executive Summary |
2.Global Critical Illness Insurance Market Introduction |
2.1.Global Critical Illness Insurance Market - Taxonomy |
2.2.Global Critical Illness Insurance Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Application |
2.2.3. By Region |
3.Global Critical Illness Insurance Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Critical Illness Insurance Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Critical Illness Insurance Market By Product Type , 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Disease Insurance |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Medical Insurance |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Income Protection Insurance |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Critical Illness Insurance Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Cancer |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Heart Attack |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Stroke |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Critical Illness Insurance Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Critical Illness Insurance Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Disease Insurance |
8.1.2.Medical Insurance |
8.1.3.Income Protection Insurance |
8.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Cancer |
8.2.2.Heart Attack |
8.2.3.Stroke |
8.2.4.Others |
8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Critical Illness Insurance Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Disease Insurance |
9.1.2.Medical Insurance |
9.1.3.Income Protection Insurance |
9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Cancer |
9.2.2.Heart Attack |
9.2.3.Stroke |
9.2.4.Others |
9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Critical Illness Insurance Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Disease Insurance |
10.1.2.Medical Insurance |
10.1.3.Income Protection Insurance |
10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cancer |
10.2.2.Heart Attack |
10.2.3.Stroke |
10.2.4.Others |
10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Critical Illness Insurance Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Disease Insurance |
11.1.2.Medical Insurance |
11.1.3.Income Protection Insurance |
11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cancer |
11.2.2.Heart Attack |
11.2.3.Stroke |
11.2.4.Others |
11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Critical Illness Insurance Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Disease Insurance |
12.1.2.Medical Insurance |
12.1.3.Income Protection Insurance |
12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cancer |
12.2.2.Heart Attack |
12.2.3.Stroke |
12.2.4.Others |
12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Aegon N.V. |
13.2.2.Allianz SE |
13.2.3.Aviva plc |
13.2.4.Axa S.A. |
13.2.5.China Life Insurance |
13.2.6.China Pacific Insurance Co., Ltd. |
13.2.7.Legal & General Group plc, |
13.2.8.New China Life Insurance Co., Ltd. |
13.2.9.Ping An Insurance |
13.2.10.Prudential plc |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players